Compliance Rate
Compliance Rate
0%
Compliant submissions
0
Incompliant submissions
0
Total trials
0
My Organizations' Clinical Trials
Showing 2 of 2 entries
View as:
Phase: N/A
Priority: Normal
Start: 07/31/25
End: 12/31/29
Due: 12/31/30
Phase: N/A
Priority: Normal
Start: 02/29/24
End: 08/31/27
Due: 08/31/28
| Title | NCT ID | Organization | User | Status | Start Date | End Date | Reporting Due Date | Last Checked | User Role | Org Created |
|---|---|---|---|---|---|---|---|---|---|---|
| C-CAR168 CAR T Cell Therapy for Refractory Autoimmune Disease | NCT06935474 | AbelZeta Inc. | user2@example.com | None | 2025-07-31 | 2029-12-31 | 2030-12-31 | - | - | 2025-07-14 |
| C-TIL051 in Non-Small Cell Lung Cancer | NCT05676749 | AbelZeta Inc. | user2@example.com | None | 2024-02-29 | 2027-08-31 | 2028-08-31 | - | - | 2025-07-14 |